Aurobindo Pharma Trades in Red Despite FDA Approval of Eugia Pharma Injection
Aurobindo Pharma posted a small loss on January 4 amid weaker markets. At 12:01 pm, Aurobindo Pharma was quoted at Rs 440.20, below Re 1,...
Tag : Aurobindo Pharma
Aurobindo Pharma Rises on Bargain Hunting
Aurobindo Pharma gained 1.35 per cent to Rs 462.40 on bargain hunting. The stock dropped 7.21 per cent in seven days of trading sessions at...
Aurobindo Pharma Arm Gets USFDA Approval for Fungal Infection Treatment Injection
Aurobindo Pharma said on Friday that its wholly-owned subsidiary Eugia Pharma Specialties had received final approval from the United States Food and Drug Administration (USFDA)...
Nifty Drops Below 18,250 Level
In the domestic market, barometers extended losses and hit fresh trade low in the morning trade. The Nifty traded tad below the 18,250 level. Also,...
Aurobindo Pharma Hits Over 2-Year Low on Weak Q2 Results
Aurobindo Pharma’s shares went down by 7 per cent to hit an over last two years below Rs 457.20 on the Bombay Stock Exchange (BSE)...
Aurobindo Pharma Shares Fall 6% After Reports of Sarath Reddy’s Arrest by ED
Shares of Aurobindo Pharma fell more than 6% to a low of Rs 506.90 intraday on Thursday after reports that its director Sarath Reddy was...
Aurobindo Pharma Falls 6% in One Week After Receiving EIR from USFDA
Shares of Aurobindo Pharma fell 1% to Rs 497.85 in intra-day trade on Tuesday for the fifth consecutive day after the company’s half-subsidiary Aurolife received...
Eugia Pharma Gets USDA Approval For Suspension of Medroxyprogesterone Acetate Injectable
The approval has been received from US Food & Drug Administration (USFDA) for Aurobindo Pharma to manufacture Medroxyprogesterone Acetate Injectable Suspension USP with 150 mg/mL,...
Aurobindo Pharma Acquires 51% Stake in GLS Pharma
Aurobindo Pharma has completed the acquisition of GLS Pharma Limited with a 51 per cent stake. In June, the Board of Aurobindo Pharma approved the...
Aurobindo Pharma Hits 52-Week Low
Shares of Aurobindo Pharma hit a fresh 52-week low of Rs 728.50 as they fell 3.4 per cent on the BSE in intra-day trade on...